drugset / Trial / NCT02688049
NeuroRegen Scaffold™ Combined With Stem Cells for Chronic Spinal Cord Injury Repair
Phase 1/2
Unknown
30 enrolled
Chinese Academy of Sciences
Affiliated Hospital of Logistics University of CAPF · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the efficacy and safety of mesenchymal stem cells or neural stem cells combined with NeuroRegen scaffold transplantation in patients with spinal cord injury.
Timeline
- Start
- 2016-01
- Primary completion
- 2021-12
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | 1e+07 cells | — |
| Subject | neural stem cells | Cell therapy | 1e+07 cells | — |